# Evaluating the Safety, Tolerability, and Pharmacokinetics of BIIB095 in Healthy Participants

> **NCT03454126** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 80 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** BIIB095
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03454126
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-29
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03454126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03454126, "Evaluating the Safety, Tolerability, and Pharmacokinetics of BIIB095 in Healthy Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03454126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*